000 | 01018 a2200313 4500 | ||
---|---|---|---|
005 | 20250515043800.0 | ||
264 | 0 | _c20061114 | |
008 | 200611s 0 0 eng d | ||
022 | _a0017-5749 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFernández-Nebro, A | |
245 | 0 | 0 |
_aAnti-TNF-alpha for treatment of amyloidosis associated with Crohn's disease. _h[electronic resource] |
260 |
_bGut _cNov 2006 |
||
300 |
_a1666-7; author reply 1667 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Comment; Letter | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAmyloidosis _xdrug therapy |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aCrohn Disease _xcomplications |
650 | 0 | 4 | _aFatal Outcome |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfliximab |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aUreña, I | |
700 | 1 | _aIrigoyen, M V | |
700 | 1 | _aGarcía-Vicuña, R | |
773 | 0 |
_tGut _gvol. 55 _gno. 11 _gp. 1666-7; author reply 1667 |
|
999 |
_c16622732 _d16622732 |